;
Tissue Diagnostics Market Global Industry Analyses 2016-2020 an Opportunity Forecasted 2020-2030
Tissue diagnostics is analyzing and evaluating particular tissue samples in order to understand the biological background of illnesses. They are used to detect specific medical problems including as cancer and inflammatory illnesses, as well as indicate the precise kind and degree of malignancy, which aids in the identification of probable causes and treatment choices. Tissue diagnostics are very accurate, low-cost, and may be done using a variety of procedures, including core and open biopsy. These diagnoses are now performed using modern technologies such as immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special labelling. The disease insights and factors that influence patient outcomes are captured by tissue diagnostics. Tissues, in general, provide for individualized diagnosis and therapy. The majority of samples are made up of tissue fragments collected through various procedures. Small biopsies and huge specimens extracted during surgery are examples. Other important factors driving the market's growth are rising healthcare expenditures and technical developments in tissue diagnostics.
Abbott Laboratories
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
The number of persons diagnosed with cancer has increased as a result of changing lifestyles, increased cigarette and alcohol intake, and rising incidence of lifestyle problems. The need for tissue diagnostics in the treatment of breast cancer, prostate cancer, and other cancers is propelling the market during the forecast period, owing to a growth in the population and an increase in chronic illnesses throughout the world.
In 2019, Roche and GE Healthcare have agreed to collaborate on the development of an integrated digital diagnostics platform aimed at improving cancer and critical care therapy.
In 2019, Hologic received CE permission for ThinPrep Genesis Processor.
Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT